WallStreetZenWallStreetZen

NYSE: WST
West Pharmaceutical Services Inc Stock

Open Broker Account
$234.99-4.45 (-1.86%)
Updated Dec 6, 2022
WST Price
$234.99
Fair Value Price
N/A
Market Cap
$17.40B
52 Week Low
$206.19
52 Week High
$475.00
P/E
27.88x
P/B
7.04x
P/S
6.29x
PEG
3.28x
Dividend Yield
0.31%
Revenue
$2.91B
Earnings
$630.60M
Gross Margin
40.4%
Operating Margin
26.11%
Profit Margin
21.7%
Debt to Equity
0.34
Operating Cash Flow
$654M
Beta
0.84
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

WST Overview

West Pharmaceutical Services Incorporated manufactures and sells containment and delivery systems for injectable drugs and healthcare products in the U.S. and internationally. Its Proprietary Products segment offers stoppers and seals for injectable packaging systems, and syringe and cartridge components for injectable drug applications. The Contract-Manufactured Products segment manufactures and (automated) assembles devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. It serves pharmaceutical and medical device companies. The company was incorporated in 1923 and is headquartered in Exton, PA.

Zen Score

Industry Average (33)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how WST scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

WST ($234.99) is trading above its intrinsic value of $73.36, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
WST is poor value based on its earnings relative to its share price (27.88x), compared to the US market average (21.59x)
P/E vs Market Valuation
WST is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more WST due diligence checks available for Premium users.

Be the first to know about important WST news, forecast changes, insider trades & much more!

WST News

Valuation

WST price to earnings (PE)

For valuing profitable companies with steady earnings
Company
27.88x
Industry
-67.03x
Market
21.59x
WST is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
WST is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation

WST price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
7.04x
Industry
3.51x
WST is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

WST price to earnings growth (PEG)

For valuing profitable companies with growth potential
WST is poor value relative... subscribe to Premium to read more.
PEG Value Valuation

WST's financial health

Profit margin

Revenue
$686.9M
Net Income
$120.6M
Profit Margin
17.6%
WST's Earnings (EBIT) of $759.40M... subscribe to Premium to read more.
Interest Coverage Financials
WST's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$3.3B
Liabilities
$846.0M
Debt to equity
0.34
WST's short-term assets ($1.73B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
WST's short-term assets ($1.73B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
WST's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
WST's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$168.9M
Investing
-$59.1M
Financing
-$75.2M
WST's operating cash flow ($654.00M)... subscribe to Premium to read more.
Debt Coverage Financials

WST vs Medical Stocks

TickerMarket Cap1d %P/EP/B
WST$17.40B-1.86%27.88x7.04x
HOLX$18.25B-1.18%14.33x3.74x
STE$18.32B-1.02%-2,294.63x3.16x
COO$15.45B-2.63%36.07x2.18x
TFX$11.07B+0.08%26.78x2.84x

West Pharmaceutical Services Stock FAQ

What is West Pharmaceutical Services's quote symbol?

NYSE: WST) West Pharmaceutical Services trades on the NYSE under the ticker symbol WST. West Pharmaceutical Services stock quotes can also be displayed as NYSE: WST.

If you're new to stock investing, here's how to buy West Pharmaceutical Services stock.

What is the 52 week high and low for West Pharmaceutical Services (NYSE: WST)?

(NYSE: WST) West Pharmaceutical Services's 52-week high was $475.00, and its 52-week low was $206.19. It is currently -50.53% from its 52-week high and 13.97% from its 52-week low.

How much is West Pharmaceutical Services stock worth today?

(NYSE: WST) West Pharmaceutical Services currently has 74,032,987 outstanding shares. With West Pharmaceutical Services stock trading at $234.99 per share, the total value of West Pharmaceutical Services stock (market capitalization) is $17.40B.

West Pharmaceutical Services stock was originally listed at a price of $7.44 in Dec 31, 1997. If you had invested in West Pharmaceutical Services stock at $7.44, your return over the last 24 years would have been 3,059.32%, for an annualized return of 15.47% (not including any dividends or dividend reinvestments).

How much is West Pharmaceutical Services's stock price per share?

(NYSE: WST) West Pharmaceutical Services stock price per share is $234.99 today (as of Dec 6, 2022).

What is West Pharmaceutical Services's Market Cap?

(NYSE: WST) West Pharmaceutical Services's market cap is $17.40B, as of Dec 7, 2022.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

West Pharmaceutical Services's market cap is calculated by multiplying WST's current stock price of $234.99 by WST's total outstanding shares of 74,032,987.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.